openPR Logo
Press release

Neurogenomics Market Size, Trends & Forecast to 2032 - Emerging Innovations and Growth Drivers

07-25-2025 09:37 AM CET | Health & Medicine

Press release from: Meticulous Research®

Neurogenomics Market Size, Trends & Forecast to 2032 - Emerging

Neurogenomics Market Positioned for Rapid Growth to 2032

The Neurogenomics Market was valued at USD 1.59 billion in 2024 and is projected to grow to USD 5.48 billion by 2032. From an estimated base of USD 1.83 billion in 2025, this reflects a robust compound annual growth rate (CAGR) of 17% through the forecast period. This momentum is fueled by technological advancements, falling sequencing costs, and a growing focus on precision medicine for neurological disorders.

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=6019

Key Growth Drivers Accelerating Market Expansion

Decreasing costs of genomic sequencing and the broader availability of next generation sequencing (NGS) have enabled wider clinical adoption. As neurological conditions continue to rise globally, there is increasing demand for early and precise diagnosis. Pharmaceutical companies are scaling their R&D investments in neurogenomics, supported by favorable reimbursement policies and enhanced regulatory frameworks. Governments and healthcare initiatives are also funding large scale studies aimed at understanding and preventing neurological diseases.

Rising Burden of Neurological Disorders

Neurological conditions now affect nearly half of the world's population, contributing significantly to global disease burden. Conditions such as Alzheimer's disease, stroke, migraine, diabetic neuropathy, and post COVID cognitive impairments are escalating, with diabetic neuropathy cases alone tripling in recent decades. Pediatric neurodevelopmental disorders also impose a heavy burden. The scale and complexity of these diseases are driving demand for genomic diagnostics and targeted treatment strategies.

Precision Medicine and Targeted Therapy Opportunities

Precision medicine in neurogenomics tailors treatment based on individual genetic makeup and disease profile. This approach reduces reliance on trial and error prescribing, mitigates adverse drug reactions, and improves treatment adherence. Targeted therapies are increasingly approved for neurodegenerative and psychiatric disorders, often leveraging biomarker based diagnostics powered by NGS technology. The link between gene mutation discovery and precision therapeutics continues to fuel demand for neurogenomic tools and platforms.

Technological Advancements and Portable Sequencing

Technologies such as handheld, nanopore based sequencers are transforming the landscape by delivering fast, cost effective genomic data. These portable devices can sequence entire genomes at a cost under USD 1,000 and enable real time analysis outside centralized labs. The rise in portable sequencing technology is opening new pathways for research, clinical screening, and point of care diagnostics, thereby expanding access to neurogenomics in both research and clinical settings.

Market Restraints and Challenges

High costs of sequencing platforms and assays remain a barrier, especially for smaller labs. Many cases still yield few actionable findings, limiting the impact on precision treatments. Ethical, privacy, and legal dilemmas around genetic data also complicate the adoption process. Moreover, the lack of skilled professionals, limited infrastructure in emerging markets, and high capital requirements pose challenges to broader deployment.

Browse in Depth : https://www.meticulousresearch.com/product/neurogenomics-market-6019

Research Applications Drive Market Share

In 2024, research applications accounted for approximately 61.6% of the neurogenomics market (Neurogenomik-Markt). This segment includes functional studies, variant discovery, target identification, and transcription factor binding analysis. Growing demand among academic institutions and research centers to uncover the genetic basis of complex neurological diseases, combined with broad adoption of NGS, PCR, and microarray platforms, keeps this sector at the forefront.

NGS Dominates Technology Segment

Next generation sequencing (NGS) holds the largest share-about 63.9% in 2024-within the technology category. The prevalence of recurring consumable needs, higher accuracy compared to other methods, and its central role in both research and diagnostics contribute to NGS's dominance. Throughout the forecast period, NGS is expected to exhibit the strongest growth rate due to rising genomics projects and clinical applications.

Pharmaceutical and Biotechnology Companies Lead in End Use

In 2024, pharmaceutical and biotechnology companies represented nearly 44.6% of the neurogenomics market (Marché de la neurogénomique) value. These organizations typically have the resources to invest in cutting edge genomic platforms for drug discovery and biomarker research. Academic and research institutes are projected to grow fastest, driven by increased funding, expanding lab infrastructure, and demand for genomic insights into neurological disease mechanisms.

Regional Analysis Highlights North America and Asia Pacific Growth

North America commanded the largest share in 2024, accounting for around 47.2% of the global neurogenomics market (ニューロゲノミクス市場). Dominant factors include high R&D spending in the biotech sector, favorable reimbursement policies, and the presence of leading sequencing vendors. Asia Pacific is poised for the highest CAGR-approximately 17.9% between 2025 and 2032-as countries like China and India expand healthcare infrastructure, increase diagnostic adoption, and support genomics through government initiatives.

Within Asia Pacific, rising awareness of neurological disorders and increased research funding are key growth drivers. European markets are also significant due to strong precision medicine programs, well established healthcare systems, and supportive regulatory frameworks.

Competitive Landscape and Recent Developments

Key players in the neurogenomics market include Illumina, Thermo Fisher Scientific, F. Hoffmann La Roche, QIAGEN, Agilent Technologies, Revvity, Pacific Biosciences, Danaher, Oxford Nanopore Technologies, and MGI Tech. Recent milestones include Illumina's launch of a long read/prep assay compatible with NovaSeq systems and Thermo Fisher's acquisition of Olink Proteomics. Thermo Fisher also introduced the Ion Torrent Genexus Dx platform, offering same day sequencing diagnostics.

Buy the Complete Report with an Impressive Discount: https://www.meticulousresearch.com/view-pricing/1336

Market Outlook and Strategic Implications

With neurological disorders continuing to rise and precision medicine gaining ground, the neurogenomics market is positioned for rapid advancement. Companies focusing on reducing assay costs, improving sequencing accuracy, and integrating AI driven analytics will lead the next wave of innovation. Investment in portable sequencers, data privacy frameworks, and workforce training are emerging priorities for sustained market growth.

Key questions answered in the neurogenomics market report:

What is the focus of the neurogenomics market study?

What is the size of the neurogenomics market, and at what CAGR is this market projected to grow during 2025-2032?

Which offering segment is expected to hold the major share of the market in 2024?

Which is the high-growth application segment of the neurogenomics market?

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the neurogenomics market?

Who are the major players operating in the neurogenomics market?

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

Related Reports:

China Neurogenomics Market : https://www.meticulousresearch.com/product/china-neurogenomics-market-6003

Genomics Market: https://www.meticulousresearch.com/product/genomics-market-1262

Spatial Genomics Market: https://www.meticulousresearch.com/product/spatial-genomics-market-5763

Next Generation Sequencing (NGS) Market: https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040

About Us:

We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with actionable market intelligence tailored to drive revenue transformation and strategic growth. Our insights reveal forward-looking revenue opportunities, providing our clients with a competitive edge through a diverse suite of research solutions-syndicated reports, custom research, and direct analyst engagement.

Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight key industry sectors and 20+ geographic markets. With a focus on solving the complex challenges facing global business leaders, our research enables informed decision-making that propels sustainable growth and operational excellence. We are dedicated to delivering high-impact solutions that transform business performance and fuel innovation in the competitive global marketplace.

Contact Us:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email- sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurogenomics Market Size, Trends & Forecast to 2032 - Emerging Innovations and Growth Drivers here

News-ID: 4119938 • Views:

More Releases from Meticulous Research®

Software Defined Radio Market Trends, Insights, and Outlook | Meticulous Research®
Software Defined Radio Market Trends, Insights, and Outlook | Meticulous Researc …
The global software defined radio (SDR) market (Marché de la radio définie par logiciel) is gaining momentum as communication systems continue to evolve. Valued at $21.8 billion in 2024, the market is projected to reach $49.7 billion by 2035, growing at a CAGR of 7.8% from 2025 to 2035. This growth reflects the rising demand for advanced, flexible, and cost-efficient communication solutions across defense, commercial, and government sectors. Download Sample Report
Microgrid Implementation Market to Hit $142.8B by 2035 | Meticulous Research®
Microgrid Implementation Market to Hit $142.8B by 2035 | Meticulous Research®
Global Microgrid Implementation Market Outlook (2025-2035) The global microgrid implementation market is entering a period of remarkable expansion. Valued at USD 32.1 billion in 2024, the market is projected to grow to USD 36.8 billion in 2025, before reaching USD 142.8 billion by 2035. This translates to a compound annual growth rate (CAGR) of 14.5% during the forecast period. This growth reflects the rising importance of distributed energy systems, smart grid
Carbon Accounting Software Trends and Forecasts 2025-2032 | Meticulous Research®
Carbon Accounting Software Trends and Forecasts 2025-2032 | Meticulous Research …
Global Carbon Accounting Software Market Outlook (2025-2032) The carbon accounting software market is undergoing rapid transformation, driven by the urgent need for businesses to track, manage, and reduce their carbon footprints. Valued at USD 1.4 billion in 2024, the market is expected to reach USD 1.6 billion in 2025 and grow to nearly USD 7 billion by 2032, reflecting a strong compound annual growth rate of 23 percent. This surge highlights
Digital Fashion Market: Growth, Drivers, and Future Outlook | Meticulous Research®
Digital Fashion Market: Growth, Drivers, and Future Outlook | Meticulous Researc …
The global digital fashion market has entered a phase of rapid transformation. Valued at USD 1.1 billion in 2024, it is expected to climb to USD 1.4 billion in 2025 and further expand to USD 15.5 billion by 2035, growing at a striking CAGR of 27.2%. This surge is being fueled by the fusion of immersive technology, sustainable practices, and shifting consumer behavior. Unlike traditional fashion, digital fashion thrives on creativity

All 5 Releases


More Releases for NGS

Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market. Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report. Global Next-Generation Sequencing (NGS) Services Market,
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379 The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home. Top Companies Analysis - Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter F. Hoffmann-La Roche AG Illumina, Inc.
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504 This latest report researches the industry structure,
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers